|Corporate Name||Utilization of Carbon Dioxide Institute Co., Ltd.|
|Head Office||5-13-15 Shiba, Minato-ku, Tokyo 108-0014, Japan
TEL +81-3-6435-1150 FAX +81-3-6435-1188
|Representative||Dr. Hideaki Yukawa
Chief Executive Officer
|Established||August 12, 2015|
|Paid-in Capital||30 million of yen|
|Specializations:||Molecular biology, microbial applications, enzyme chemistry|
|Education and Professional History|
|Aug. 1971||Graduated from the Faculty of Agriculture, the University of Tokyo Bioscience, Biotechnology, and Agrochemistry
Joined the Biochemistry Research Laboratory of the Tsukuba Research Center of Mitsubishi Petrochemical Co., Ltd (currently Mitsubishi Chemical Corporation)
|1983||Obtained his doctoral degree in agriculture from the University of Tokyo|
|Apr. 1991||Became Director of the Biochemistry Research Laboratory of Mitsubishi Petrochemical Co., Ltd.|
|Nov. 1993||Served concurrently as leader of establishing the bio research function of the Research Institute of Innovative Technology for the Earth|
|Apr. 1997||Appointed Research Fellow of Mitsubishi Chemical Corporation|
|Jun. 2003||Retired from Mitsubishi Chemical Corporation and began working full-time for the Research Institute of Innovative Technology for the Earth|
|Jun. 2007||Appointed Director of the Research Institute of Innovative Technology for the Earth|
|Sep. 2011||Established the Green Earth Institute Co., Ltd as founder|
|Jun. 2015||Retired as Director of the Research Institute of Innovative Technology for the Earth|
|Aug. 2015||Established the Utilization of Carbon Dioxide Institute Co., Ltd., appointed Chief Executive Officer|
|Recognitions and Commendations|
|1991||Japan Bioindustry Association Award|
|1992||Tsukuba Foundation for Chemical and Bio-Technology Award|
|1997||JSBBA Award for Achievement in Technological Research|
Grand Prize at the 18th Nikkei Global Environmental Technology Awards: “Bio-ethanol production from mixed sugars by genetically engineered Coyrnebacterium glutamicum”
|2011||Fellowship Award from The Society for Industrial Microbiology
* This award is presented for achievements in the field of applied microbiology and Mr. Yukawa became the first Japanese national to receive it in 2011. The 2015 winner was Satoshi Omura.
|Consultant in Microbial Biotechnology & Carbon Sequestration
Pacific Northwest National Laboratory (retired)
|2014 - Present||Science Advisor, Utilization of CO2 Institute, Co., LLC, Japan
Global Advisory Board Member, The Global CO2 Initiative, San Francisco CA, USA
Consultant (1997-present), Research Institute of Innovative Technology for the Earth (RITE), Japan
Consultant, Green Earth Institute Co., LLC, Tokyo
Co-Founder & Board Member (1979-present), R&A Plant-Soil, Inc., Pasco WA, USA
|1990-2014||Battelle Memorial Institute (BMI), Pacific Northwest National Laboratory (PNNL), Richland WA, USA.
PNNL is a US Department of Energy (DOE) Multiprogram Laboratory operated for the federal government by BMI, Columbus, Ohio
|1993-2014||Manager, PNNL Fundamental and Computational Sciences Product Line & Commercial Sector|
|1990-1993||Senior Research Scientist, PNN|
|1989-1990||Project Scientist, Cyanotech Corporation, Hawaii, USA (microalgae products)|
|1988-1989||Principal Microbiologist, Enviros Corporation, Redmond WA, USA (bioremediation)|
|1987-1988||Research Associate, Tufts University Medical School, Boston MA, USA (molecular ecology)|
|1987||Participant in the US-India Science & Technology Initiative sponsored by the Agency for International Development, including microalgae research centers in Bangalore, Madurai and Delhi.|
|1979-1987||Co-Founder & Vice President for Research & Development, R&A Plant Soil, Inc., Pasco, WA USA. Current member, corporate Board of Directors.|
|1979||Ph.D., Washington State University (Botany)|
|1975||M.S., Washington State University (Botany)|
|1972||B.A., Whitman College (Liberal Arts)|
|1984-1986||University of Washington (MBA coursework, including Financial & Management Accounting)|
|Selected Publications: (> 40 total, including 25 refereed research articles)
(Selected to highlight breadth of research interests from Microalgae Biotechnology to Carbon Sequestration)
CT Garten Jr., DJ Brice, HF Castro, RL Graham, MA Mayes, JR Phillips, WM Post III, CW Schadt, SD Wullschleger, DD Tyler, PM Jardine, JD Jastrow, R Matamala, RM Miller, KK Moran, TW Vugteveen, RC Izaurralde, AM Thomson, TO West, JE Amonette, VL Bailey, FB Metting, JL Smith. 2011. Response of “Alamo” switchgrass tissue chemistry and biomass to nitrogen fertilization in West Tennessee, USA. Agriculture, Ecosystems & Environment 140: 289-297.
CT Garten, Jr., JL Smith, DD Tyler, JE Amonette, VL Bailey, DJ Brice, HF Castro, RL Graham, CA Gunderson, RC Izaurralde, PM Jardine, JD Jastrow, MK Kerley, R Matamala, MA Mayes, FB Metting, RM Miller, KK Moran, WM Post, RD Sands, CW Schadt, JR Phillips, AM Thomson, T Vugteveen, TO West, and SD Wullschleger. 2010. Intra-annual changes in biomass, carbon, and nitrogen dynamics at 4-year old switchgrass field trials in West Tennessee, USA. Agriculture, Ecosystems & Environment 136: 177-184
M Huesemann, G Roesjadi, JR Benemann and FB Metting. 2009. Biofuels from Microalgae and Seaweeds. In: Biomass to Biofuels. Strategies for Global Industries. A.A. Vertes, H. Yukawa et al., (Eds.). Wiley & Sons, New York.
WM Post, JE Amonette, R Birdsey, CT Garten Jr., RC Izaurralde, PM Jardine, JD Jastrow, R Lal, G Marland, BA McCarl, AM Thomson, TO West, SD Wullschleger, and FB Metting. 2009. Terrestrial Biological Carbon Sequestration: Science for Enhancement and Implementation. In (B. McPherson and E. Sundquist, Eds.) Science and Technology of Carbon Sequestration, Geophysical Monograph 183, American Geophysical Union.
B McCarl, FB Metting, C Rice (co-Editors.). 2007. Special Issue: The Science, Technology & Economics of Soil Carbon Sequestration for Mitigation of Greenhouse Gases. Climatic Change 80: 1-197.
NJ Rosenberg, FB Metting. RC Izaurralde (co-Editors). 2004. Applications of Biotechnology to Mitigation of Greenhouse Warming. Proceedings, 2nd St. Michaels Workshop. Battelle Press, Columbus.
Metting, FB. 1996. Biodiversity and applications of microalgae. Journal of Industrial Microbiology 17, 477-489. (special volume) D. E. Eveleigh and J. C. Hunter-Cevera (co-Editors).
MJ Graham, J.M Thomas and FB Metting. 1996. Groundwater. Chapter 11 In: Handbook of Water Resources. L. W. Mays (Editor-in-Chief). McGraw-Hill.
Metting, FB. 1994. Algae and cyanobacteria. Chapter 18 (pp. 427-458) In: Methods of Soil Analysis. Part 3. Microbiological and Biochemical Properties. 3rd edition. R. W. Weaver et al. (Eds.) American Society of Agronomy/Soil Science Society of America, Madison, Wisconsin.
Metting, FB. Editor. 1993. Soil Microbial Ecology. Applications in Agricultural and Environmental Management. Marcel Dekker, New York City. 646 pp. (Dr. Metting wrote or co-authored 4 chapters)
pre-1990: Contributed chapters to volumes entitled Algae and Human Affairs (Cambridge University Press), Micro-algae Biotechnology (Wiley Interscience), Applied Phycology (Klyuvier), The Rhizosphere (Wiley & Sons), Semi-Arid Lands and Deserts (2 chapters, Taylor & Francis); and refereed research articles in Applied & Environmental Microbiology, Applied Phycology Forum, Journal of Phycology, Phycologia (2), Arid Land Management, Soil Science (2), and Soil Science of America Journal.
|Managing Director at NxR Biotechnologies|
Dr. Alain Vertès is Managing Director at NxR Biotechnologies, a global boutique consulting firm based in Basel, Switzerland, where he advises on strategy, business development (partnering, alliance management, in- and out-licensing, commercialisation), entrepreneurship and investment in the pharmaceutical, biotechnology, and sustainable chemistry industries. NxR's track record comprises projects with big pharmas, biotechs, generics companies, financial investors, CROs, academia, and start-ups.
Dr. Vertès came to this role after extensive experience in the pharmaceutical and industrial biotechnology sectors, in Europe, North America, and Asia in different functions including research, manufacturing, partnering, and sales, in pharmaceuticals (Lilly, Pfizer, Roche), petrochemicals (Mitsubishi Chemical Corporation), public research (Institut Pasteur; RITE/Kyoto), contract research (Battelle Memorial Institute, PPD/BioDuro) and consulting (Australian Strategic Policy Institute). Focusing on innovation commercialization, he was a key player in the evaluation, selection, deal making, implementation, and alliance management of novel products and emerging technologies. For example, he championed radical innovation for bringing to patients disease-modifying, paradigm-changing therapeutics such as siRNA (Scrip Award 2008) and led in a scientific, strategic, and business manner Roche’s global cell therapeutics strategy and implementation team from 2007-2010.
Dr. Vertès received an M.Sc. degree from the University of Illinois at Urbana-Champaign, a PhD from the University of Lille Flandres Artois, and is a Sloan Fellow from London Business School (MBA/M.Sc.).
Vertès, A. A., Qureshi, N., Caplan, A. I., & Babiss, L. E. (Eds.). (2015). Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies. John Wiley & Sons.
Vertès, A. A., & Dowden, N. J. (2015). History of monoclonal antibodies and lessons for the development of stem cell therapeutics. Stem Cells in Regenerative Medicine: Science, Regulation and Business Strategies, 665-692.
Vertès, A. A. (2015). The potential of cytotherapeutics in hematologic reconstitution and in the treatment and prophylaxis of graft-versus-host disease. Chapter II: Emerging Transformational Cytotherapies. Regenerative Medicine, 10(3), 345-373.
Bayon, Y., Vertès, A. A., Ronfard, V., Culme-Seymour, E., Mason, C., Stroemer, P., … & Aras, R. (2015). Turning Regenerative Medicine Breakthrough Ideas and Innovations into Commercial Products. Tissue Engineering Part B: Reviews, 21(6), 560-571.
Bayon, Y., Vertès, A. A., Ronfard, V., Egloff, M., Snykers, S., Salinas, G. F., … & Kemp, P. (2014). Translating cell-based regenerative medicines from research to successful products: challenges and solutions. Tissue Engineering Part B: Reviews, 20(4), 246-256.
Vertès, A. A. (2014). Deciphering the therapeutic stem cell strategies of large and midsize pharmaceutical firms. Regenerative Medicine, 9(4), 479-495.
Bayon, Y., Ellison, S., Vertès, A., Ahmed, A., Coury, A. J., Campion, C., … & Hellman, K. B. (2013). Commercialization of regenerative products: the academic/industry partnership. Tissue Engineering Part B: Reviews, 20(4), 243-245.
Vertès, A. A. (2012). Syndicate innovation venturing: translating academic innovations into commercial successes. Challenges, 3(2), 70-83.
Vertès, A. A. (2010). Adoption of Therapeutic Stem Cell Technologies by Large Pharmaceutical Companies. The Delivery of Regenerative Medicines and Their Impact on Healthcare, 153-175.